Primary Care Enhanced Services
Overview
Summary, notice description and lot information
The NHS Lincolnshire Integrated Care Board is in the process of awarding a contract for Primary Care Enhanced Services, under the Health Care Services (Provider Selection Regime) Regulations 2023. This procurement is categorised under health services with CPV code 85100000 and follows a limited procurement method without prior publication of a call for competition. The intention to award notice marks the onset of the standstill period, ending on 1st September 2025, during which representations can be submitted.
The procurement location is the UKF3 region, with NHS Lincolnshire Integrated Care Board based in Sleaford as the buyer. The contract, valued at £146,383, is intended for the provision of services such as phlebotomy and specialised drug monitoring, with existing provider Beacon Medical Practice identified as the supplier. This tender presents significant opportunities for businesses in the health services sector, specifically those that can provide high-quality and innovative primary care services.
The awarded contract is for existing services, ensuring continuity and potential for further expansion. Businesses such as local clinics, pharmacies, and independent healthcare providers with experience in areas like safeguarding and specialised drug monitoring might find such contracts beneficial for growth. As the procurement process highlights the emphasis on quality, collaboration, and service sustainability, organisations with a robust track record in these areas are well-positioned to compete in future similar procurements.
The process is designed to improve access and reduce health inequalities, thereby aligning with organisations committed to providing social value through their services.
NHS Lincolnshire ICB is intending to utilise direct award process C of the Provider Selection Regime regulations to award a contract for the provision of: - Primary Care Enhanced Services, including: Phlebotomy, DOAC, Gonadorelins (Zoladex), Specialised Drug Monitoring, Safeguarding
NHS Lincolnshire ICB is intending to utilise direct award process C of the Provider Selection Regime regulations to award a contract for the provision of: - Primary Care Enhanced Services, including: Phlebotomy, DOAC, Gonadorelins (Zoladex), Specialised Drug Monitoring, Safeguarding . The contract duration is from 1st April 2025 to 31st March 2026 and the expected value of the activity for the lifetime of the contract is PS146383 The provider is an existing provider and the services are existing services.
Procurement Classification
Notice type, method, and CPV codes
Contract Values
Financial information and value estimates
Contract duration information not available.
Key Dates
Publication, submission, and award timeline
Notice Status
Current status of tender, lots, awards, and contracts
Contracting Authority
Buyer organisation and contact details
Awarded Supplier
Supplier who was awarded this contract
Documents & Links
External resources and data downloads
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector.
Need help with your tender submission?
Our expert team can help you prepare a winning bid. Get professional support from CareSync Experts.
Get in touch with our team at Care Sync Experts today for a consultation.
Email: hello@caresyncexperts.co.uk
Phone: 0333 577 0877
Contact UsBidding for contracts like this
Other tenders in North Kesteven
- Tobacco Dependency Service in North Kesteven
- Specialist Neighbourhood Nurses Services in North Kesteven
- Provision of Intermediate Minor Oral Surgery and Conscious Sedation at Oasis - Lincoln in North Kesteven
- Specialist Neighbourhood Nurses Services in North Kesteven
- Specialist Neighbourhood Nurses Services in North Kesteven
- GP Practice Medical Cover for Hospice in the Hospital in North Kesteven